CRAX index for prediction of morbidity among hospitalized patients with Influenza (A) H1N1 infection Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021
Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Predictors of in-hospital mortality in influenza infection. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Varicella-Zoster virus pneumonia in an adult population. Has the mortality decreased? Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010
Radiological findings and correlation to clinical outcome in patients admitted due to influenza A (H1N1) infection Source: Annual Congress 2013 –Viral infections Year: 2013
Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020
Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Clinical feature of 4 cases of severe pneumonia in pregnant women with influenza A(H1N1) virus infection Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010
Vitamin D levels and risk of infection, assessment for disease severity, and predictor of mortality in the Chinese intensive care units: A prospective cohort study Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005
Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Prevalence and risk factors for pneumonia in a cohort with clinical suspicion of influenza A (H1N1) Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Obesity and risk of pneumonia in patients with influenza Source: Eur Respir J 2011; 37: 1298 Year: 2011
Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004